background
four
speci
human
bocavirus
identifi
base
phylogenet
analysi
sinc
first
report
associ
respiratori
diseas
wherea
mainli
detect
enter
infect
although
preval
hbov
human
studi
region
well
address
global
methodologyprincip
find
crossreact
antibodi
detect
mous
human
serum
preval
specif
igg
antibodi
determin
differ
age
group
healthi
individu
age
year
old
beij
china
use
competit
elisa
assay
base
viruslik
particl
seropreval
respect
children
age
year
n
wherea
seropreval
respect
healthi
adult
year
old
n
seroposit
rate
higher
individu
older
year
furthermor
igg
seroconvers
found
pair
sera
collect
children
respiratori
tract
infect
posit
accord
pcr
analysi
conclusionssignific
data
indic
preval
popul
sampl
beij
china
suggest
hbov
speci
may
play
differenti
role
diseas
human
bocaviru
hbov
member
parvovirida
famili
potenti
etiolog
agent
respiratori
diseas
acut
gastroenter
base
phylogenet
analysi
viral
genom
four
speci
hbov
identifi
associ
respiratori
tract
diseas
detect
respiratori
tract
associ
mainli
stool
sampl
detect
enter
infect
howev
hbov
frequent
codetect
viral
infect
patient
respiratori
enter
infect
exact
role
hbov
pathogen
unclear
hbov
small
nonenvelop
virus
linear
singlestrand
dna
genom
approxim
kb
length
genom
consist
four
open
read
frame
orf
encod
two
nonstructur
protein
two
overlap
capsid
protein
lack
wellestablish
cell
cultur
system
anim
model
propag
hbov
hamper
understand
infect
pathogen
hbov
studi
shown
protein
harbor
major
antigen
hbov
form
empti
viruslik
particl
vlp
mimic
hbov
virion
morpholog
antigen
vlp
success
use
antigen
detect
antibodi
hbov
current
detect
hbov
nucleic
acid
primarili
use
estim
preval
hbov
speci
clinic
sampl
preval
mainli
detect
children
two
year
old
patient
suffer
acut
respiratori
tract
infect
arti
worldwid
detect
pcr
analysi
detect
rate
dna
stool
sampl
report
respect
preval
higher
children
adult
accord
studi
howev
data
collect
patient
may
repres
hbov
infect
gener
popul
subclin
infect
occur
hbov
persist
nasopharynx
seroepidemilog
investig
healthi
popul
may
use
patient
studi
assess
preval
spread
exposur
distribut
hbov
popul
seropreval
data
also
allow
comparison
frequenc
natur
infect
frequenc
viru
individu
infect
howev
previou
seroepidemiolog
studi
hbov
mainli
focus
specif
igg
antibodi
frequent
detect
children
seroposit
rate
rang
children
four
year
old
four
year
old
seroposit
rate
igg
antibodi
healthi
adult
howev
kantola
et
al
recent
show
crossreact
vlp
larg
affect
seroposit
data
hbov
speci
show
deplet
crossreact
antibodi
approxim
seropreval
adult
respect
howev
sampl
use
studi
collect
healthi
young
peopl
narrow
rang
age
includ
subject
age
year
finland
subject
age
year
pakistan
given
preval
viru
infect
may
vari
age
well
geograph
remain
need
estim
seropreval
hbov
base
detect
antibodi
data
complet
age
rang
global
geograph
region
present
studi
use
competit
elisa
celisa
assay
estim
seropreval
healthi
chines
individu
rang
age
year
beij
china
also
compar
seroconvers
antihbov
igg
antibodi
pair
serum
sampl
arti
children
posit
pcr
find
provid
inform
data
evalu
preval
patholog
role
hbov
produc
antigen
use
evalu
seropreval
hbov
gene
express
baculoviru
gener
vlp
gene
amplifi
stool
sampl
pcr
sequenc
gene
verifi
phylogenet
analysi
figur
gene
respiratori
stool
specimen
similar
sequenc
strain
use
studi
cluster
refer
strain
homolog
strain
ident
refer
strain
strain
ident
refer
strain
find
posit
sampl
gene
synthes
accord
sequenc
strain
protein
express
insect
cell
use
baculoviru
express
system
gener
hbov
vlp
verifi
ultracentrifugepurif
electron
microscopi
em
typic
parvoviruslik
particl
nm
size
similar
particl
infecti
parvoviru
virion
visual
em
data
shown
purifi
vlp
also
reactiv
murin
antisera
specif
protein
respect
hbov
speci
western
blot
assay
figur
sequenc
align
show
high
amino
acid
ident
hbov
speci
ident
ident
ident
ident
ident
ident
data
shown
indic
possibl
crossreact
hbov
speci
evalu
potenti
crossreact
examin
reactiv
vlp
purifi
mous
antisera
use
western
blot
elisa
assay
western
blot
analysi
show
antisera
react
ng
vlp
hbov
speci
indic
detect
specif
band
kd
size
figur
similar
crossreact
also
detect
elisa
assay
figur
mous
sera
react
strongli
homolog
vlp
moreov
four
antisera
react
heterolog
hbov
vlp
concentr
mice
antiserum
high
mgml
signific
reactiv
observ
human
parvoviru
influenza
viru
hemaglutinin
antiserum
figur
result
consist
report
kantola
et
al
develop
elisa
assay
detect
antibodi
hbov
speci
first
sought
identifi
hbovposit
andneg
sera
sampl
use
western
blot
analysi
obtain
neg
sera
sampl
test
reactiv
sera
sampl
collect
infant
age
month
visit
beij
children
hospit
regular
health
checkup
hbov
vlp
sampl
neg
vlp
simultan
select
neg
sampl
neg
sampl
confirm
use
competit
elisa
celisa
assay
absorb
valu
nm
chang
significantli
without
competit
assay
figur
serum
sampl
identifi
celisa
posit
individu
hbov
speci
obtain
children
adult
use
posit
control
howev
obtain
serum
sampl
posit
base
assay
use
sampl
adult
igg
posit
determin
concentr
vlp
requir
exhaust
antibodi
competit
serum
sampl
monocompet
concentr
vlp
rang
mgml
figur
found
hbov
vlp
concentr
mgml
effect
concentr
perform
vlpbase
competit
assay
determin
seropreval
human
develop
elisa
protocol
detect
igg
antibodi
use
vlp
coat
antigen
concentr
coat
vlp
mgml
elisa
assay
optim
use
chessboard
titrat
test
posit
sera
neg
sera
show
differ
result
serum
dilut
result
obtain
use
lower
serum
dilut
similar
obtain
data
shown
dilut
use
subsequ
elisa
analysi
serum
sampl
determin
cutoff
valu
elisa
determin
mean
valu
standard
deviat
neg
sera
use
hbov
vlp
elisa
dilut
use
mean
absorb
nm
neg
sera
plu
threefold
standard
deviat
cutoff
valu
previous
describ
cutoff
valu
respect
sampl
consid
posit
absorb
nm
cutoff
valu
respect
speci
elisa
crossreact
hbov
speci
elisa
assay
develop
celisa
assay
evalu
seropreval
hbov
speci
evalu
specif
protocol
use
heterolog
competit
assay
parvoviru
human
parvoviru
neither
human
parvoviru
inhibit
reactiv
igg
serum
adult
children
figur
result
suggest
antigen
crossreact
hbov
human
parvoviru
hbov
confirm
specif
elisa
protocol
test
sera
adult
posit
human
parvoviru
hbov
vlp
elisa
detect
falseposit
signal
hbov
data
shown
determin
seropreval
adult
use
hbov
vlp
elisa
method
detect
igg
antibodi
serum
sampl
collect
healthi
individu
year
old
without
competit
sampl
posit
sampl
posit
tabl
howev
igg
seropreval
decreas
competit
vlp
heterolog
hbov
speci
figur
celisa
result
seropreval
igg
respect
seroposit
rate
higher
x
tabl
figur
twentyf
adult
sampl
posit
igg
antibodi
posit
elisa
neg
igg
hbov
celisa
among
posit
serum
sampl
singl
hbov
speci
eight
two
base
celisa
result
seroposit
rate
children
increas
age
accord
result
elisa
without
competit
rate
reach
respect
age
group
year
seropreval
among
children
age
year
year
increas
tabl
howev
accord
result
celisa
seropreval
igg
decreas
tabl
figur
seropreval
among
children
age
year
children
age
year
increas
respect
celisa
note
among
infant
age
month
two
posit
igg
one
posit
detect
hbov
igg
antibodi
among
children
age
month
may
due
presenc
matern
antibodi
howev
seroposit
rate
higher
age
group
year
year
year
x
x
x
respect
base
result
celisa
individu
posit
nine
two
among
posit
serum
sampl
singl
hbov
speci
notabl
two
sampl
posit
igg
also
posit
igg
character
antibodi
respons
hbov
infect
measur
igg
antibodi
pair
sera
sampl
collect
children
arti
children
posit
accord
pcr
analysi
base
celisa
seropreval
acutephas
sera
respect
sampl
ten
show
igg
seroconvers
eight
two
none
two
pair
sera
show
concurr
seroconvers
one
pair
show
concurr
seroconvers
addit
absorb
nm
increas
convalescentphas
serum
observ
seven
children
posit
igg
eight
children
posit
igg
posit
acutephas
studi
evalu
crossreact
mous
antisera
vlp
four
speci
human
bocavirus
consider
crossreact
found
among
four
hbov
speci
howev
human
igg
antibodi
hbov
cross
react
human
parvoviru
find
consist
previou
report
suggest
obtain
accur
data
seropreval
differ
hbov
speci
necessari
correct
crossreact
four
hbov
comparison
protein
sequenc
reveal
high
degre
similar
similar
may
account
crossreact
virus
confirm
epitop
analysi
human
parvoviru
antigen
crossreact
hbov
suggest
human
parvoviru
antibodi
interfer
hbov
seropreval
result
specif
human
bocaviru
vlpbase
elisa
human
sera
also
demonstr
human
parvoviru
parv
kantola
et
al
use
vlpbase
elisa
assess
seropreval
healthi
individu
beij
china
rang
year
old
result
show
seropreval
rang
children
year
old
adult
elimin
interfer
antibodi
crossreact
result
correct
celisa
result
celisa
suggest
seropreval
hbov
significantli
lower
obtain
without
competit
especi
adult
find
indic
high
degre
antigen
crossreact
find
consist
recent
studi
finish
pakistani
individu
seropreval
hbov
decreas
deplet
heterolog
hbov
reactiv
antibodi
result
celisa
lower
previous
report
adult
children
antibodi
detect
elisa
henc
seropreval
hbov
may
overestim
due
serolog
crossreact
among
four
hbov
speci
previou
studi
howev
accord
celisa
result
seropreval
beij
adult
somewhat
higher
report
finnish
pakistani
adult
dispar
may
attribut
differ
geograph
locat
age
stratif
data
indic
hbov
circul
wide
human
popul
primari
infect
occur
children
age
six
month
older
matern
antibodi
wane
seroposit
rate
igg
antibodi
lower
individu
year
old
data
indic
predomin
circul
speci
hbov
beij
wherea
seem
major
impact
hbov
infect
find
agre
report
hbov
preval
obtain
part
world
use
dna
analysi
note
find
seropreval
much
lower
consist
rare
detect
dna
clinic
sampl
overal
seropreval
hbov
indic
result
celisa
decreas
less
children
adult
comparison
result
without
competit
indic
hbov
infect
specif
children
especi
result
suggest
hbov
speci
may
play
differenti
role
diseas
result
show
adult
posit
igg
base
elisa
result
neg
igg
four
hbov
base
celisa
result
find
may
due
antibodi
wane
individu
low
igg
level
lowaffin
antibodi
assess
antibodi
respons
igg
children
acut
respiratori
tract
infect
use
celisa
determin
seroconvers
rate
pair
sera
children
posit
accord
pcr
analysi
found
seropreval
higher
convalesc
sera
acut
sera
howev
heterotyp
seroconvers
also
observ
moreov
patient
posit
igg
acut
phase
absorb
valu
higher
convalesc
sera
data
may
suggest
concurr
product
antibodi
infect
shown
bcell
memori
boost
either
homolog
viru
heterolog
yet
immunolog
relat
viru
overal
find
suggest
differenti
preval
hbov
speci
healthi
individu
age
year
old
appear
domin
speci
respons
hbov
infect
among
beij
china
seropreval
increas
age
children
studi
provid
basi
futur
evalu
epidemiolog
genotyp
distribut
pathogenesi
hbov
worldwid
serum
specimen
collect
healthi
individu
age
year
specimen
infant
children
visit
beij
children
hospit
regular
health
checkup
specimen
adult
provid
beij
blood
center
exclus
criteria
subject
includ
pregnanc
abnorm
renal
liver
function
test
hivaid
sexual
transmit
diseas
tumor
recurr
acut
infect
medic
none
subject
respiratori
infect
least
three
month
prior
blood
sampl
taken
addit
pair
acutephas
time
admiss
convalesc
phase
week
diseas
onset
serum
sampl
collect
children
median
age
month
rang
month
year
acut
lower
respiratori
tract
infect
alrti
hospit
beij
children
hospit
dna
detect
nasopharyng
aspir
patient
time
admiss
nest
pcr
sequenc
analysi
use
primer
target
viral
protein
vp
region
serum
sampl
store
prior
use
written
inform
consent
obtain
particip
guardian
behalf
children
studi
approv
ethic
review
committe
institut
pathogen
biolog
chines
academi
medic
scienc
fulllength
gene
use
viruslik
particl
vlp
product
studi
gene
amplifi
hbovposit
stool
specimen
genbank
access
number
bp
nt
accord
strain
genbank
access
number
bp
nt
accord
strain
genbank
access
number
bp
nt
accord
strain
genbank
access
number
length
gene
bp
length
base
strain
genbank
access
number
synthes
sangon
biotech
shanghai
china
gene
verifi
phylogenet
analysi
use
clustal
w
megalign
program
mega
softwar
packag
phylogenet
tree
bootstrap
replic
gener
base
complet
sequenc
gene
use
studi
refer
sequenc
genbank
strain
strain
strain
strain
use
refer
sequenc
genbank
access
number
respect
fulllength
gene
clone
baculoviru
express
vector
express
use
bactobach
baculoviru
express
system
invitrogen
carlsbad
ca
accord
manufactur
protocol
vlp
obtain
previous
describ
high
five
cell
invitrogen
infect
recombin
baculovirus
multipl
infect
moi
five
harvest
three
day
cell
suspend
mm
nahco
solut
cellsml
kept
ice
min
centrifug
rpm
min
ad
supernat
final
concentr
wv
precipit
harvest
centrifug
dissolv
cscl
solut
densiti
gml
trisedta
buffer
mmoll
tri
ph
mmoll
edta
triton
centrifug
rpm
h
rotor
centrifug
beckman
coulter
fullerton
ca
fraction
analyz
sdspage
western
blot
use
mous
sera
hbov
protein
transmiss
electron
microscop
fei
hillsboro
kv
use
verifi
morpholog
vlp
sdspage
western
blot
analysi
use
identifi
vlp
recombin
protein
also
express
e
coli
rosetta
novagen
madison
wi
cell
purifi
previous
describ
gene
use
prokaryot
clone
use
baculoviru
express
system
recombin
antigen
use
immun
mice
produc
antibodi
see
control
human
parvoviru
express
describ
previous
use
construct
provid
dr
xiaohui
zou
nation
institut
viral
diseas
control
prevent
chines
center
diseas
control
prevent
addit
gene
bp
length
nt
base
refer
sequenc
synthes
sangon
biotech
shanghai
china
clone
baculoviru
vector
recombin
baculovirus
gener
cell
use
bactobach
baculoviru
express
system
invitrogen
protocol
provid
manufactur
high
five
cell
infect
recombin
baculoviru
express
gene
moi
five
infect
cell
collect
three
day
postinfect
purifi
use
histrap
hp
ml
column
ge
healthcar
waukesha
wi
concentr
purifi
protein
determin
use
pierc
bca
protein
assay
kit
thermo
scientif
rockford
il
store
prior
use
elisa
use
determin
antihbov
antibodi
describ
elsewher
purifi
hbov
vlp
use
coat
antigen
mgml
absorb
serum
sampl
read
nm
mean
valu
duplic
sampl
calcul
sera
pool
ten
sampl
show
hbovspecif
igg
respons
use
intern
refer
experi
minim
fals
posit
result
elisa
assay
due
impur
immun
coat
antigen
coat
antigen
protein
use
prepar
mous
antibodi
deriv
baculoviru
express
system
prokaryot
express
system
balbc
mice
inject
subcutan
purifi
protein
obtain
e
coli
studi
carri
accord
anim
experi
regul
chines
govern
anim
experi
perform
facil
institut
laboratori
anim
scienc
ila
chines
academi
medic
scienc
cam
experiment
procedur
approv
licens
number
supervis
anim
protect
usag
committe
ila
cam
sera
collect
treat
mice
purifi
use
prote
sepharos
column
ge
healthcar
waukesha
wi
purifi
igg
antibodi
quantifi
use
pierc
bca
protein
assay
kit
thermo
scientif
purifi
mous
igg
antibodi
serial
dilut
mgml
mgml
sera
preimmun
mice
serv
neg
control
rabbit
antiserum
human
parvoviru
gift
dr
xia
xiao
nation
institut
viral
diseas
control
prevent
chines
center
diseas
control
prevent
mice
antiserum
influenza
viru
hemaglutinin
ha
use
unrel
control
crossreact
test
use
western
blot
analysi
elisa
measur
antibodi
specif
antigen
individu
hbov
speci
antibodi
serum
sampl
absorb
heterolog
vlp
three
hbov
previous
describ
briefli
hbov
vlp
serial
dilut
mgml
mgml
determin
concentr
need
effect
competit
crossreact
antibodi
detect
specif
hbov
antibodi
three
heterolog
hbov
vlp
mgml
ad
dilut
plasma
incub
hr
prior
perform
elisa
assay
parallel
heterolog
competit
human
sera
sampl
use
compet
vlp
homolog
immobil
antigen
absorb
nm
residu
absorb
valu
net
absorb
valu
calcul
subtract
residu
absorb
valu
raw
absorb
valu
read
nm
seroposit
rate
evalu
use
x
test
p
valu
consid
signific
